Advertisement
Screener

RALLYBIO CORPORATION (RLYB) ROA

RALLYBIO CORPORATION (RLYB) ROA

  • 2026-06-30: ROA 46.45%.
  • 2026-03-31: ROA -14.35%.
  • 2025-12-31: ROA -14.42%.
  • 2025-09-30: ROA -20.94%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-3046.45%
2026-03-31-14.35%
2025-12-31-14.42%
2025-09-30-20.94%
2025-06-30-81.67%
2025-03-31-83.10%
2024-12-31-84.83%
2024-09-30-84.77%
2024-06-30-79.93%
2024-03-31-76.77%
2023-12-31-64.49%
2023-09-30-52.95%
2023-06-30-47.79%
2023-03-31-42.80%
2022-12-31-36.94%
2022-09-30-43.76%
2022-06-30-35.15%
2022-03-31-28.48%
2021-12-31-25.81%
2021-09-30-23.27%
2021-06-30-35.03%

Annual ROA

DateROA
2025-12-31-14.42%
2024-12-31-84.83%
2023-12-31-64.49%
2022-12-31-36.94%
2021-12-31-25.81%
2020-12-31-18.64%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Acrivon Therapeutics, Inc. (ACRV)United States$0.091B-1.03
ONCOLYTICS BIOTECH INC (ONCY)$0.086B
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92
Telomir Pharmaceuticals, Inc. (TELO)United States$0.084B
Anixa Biosciences Inc (ANIX)United States$0.096B
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
Lifevantage Corp (LFVN)United States$0.078B15.40